BNET Industries
Last Fiscal Year Sales:$17.5M
- Private
- US
Dow Jones Description
A global leader in research-based drug development, Medpace builds strong strategic partnerships with select Sponsors to advance the most efficient and cost-effective path to drug approval. As a therapeutically-focused Clinical Research Organization (CRO), we view ourselves as stewards of your drug, leveraging our extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. From custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, Medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents. The advantage of expertise. Led by top therapeutic and regulatory experts with extensive experience in the advancement of pharmaceutical agents for use in multiple therapeutic specialties, Medpace has cultivated a culture of expertise. Following our unique partnering philosophy, our dedicated teams serve as an extension of your team, ensuring unmatched expediency from start to finish. Before we even begin a trial, the Medpace proactive industry experts are already working on the right answers to streamline your development process and accelerate time to product approval. With an enviable track record of regulatory submissions around the globe, it's no wonder our partners view Medpace as a trusted advisor for the entire clinical development process. ...
President and CEO of Medpace
August TroendleNumber of Employees 374
Peer Companies
NAICS Code Administrative Management and General Management Consulting Services: 541611
Recent Events
-
Medpace acquires Swiss firm Pharma Brains
-
Amarin selects Medpace for two Phase III cardiovascular trials
-
Amarin Appoints Medpace as CRO for Two Phase 3 Cardiovascular Trials
News & Analysis
Filter by
medpace inc. - All News and Analysis
Medpace Inc. Takes the Top Spot as the Best CRO for Overall Working Relationship as Rated by U.S. Investigative Sites in CenterWatch, 2009 Site Survey
- 2009-06-03
Medpace, a global full-service clinical research organization, today announced it has been named the 2009 Top Clinical Research Organization CRO by CenterWatch, a highly regarded trade publication for the clinical development industry. The rating is the result of a 2009 industry-wide U.S. investigator site survey....
Medpace, Inc. Adds Medical Director, Dr. Fred Sauniere, MD, PhD, Strengthening Regulatory Expertise and Clinical Development Capabilities in Europe
- 2009-03-10
Medpace today announced the addition of Dr. Fred Sauniere, MD, PhD as a Medical Director to be located at Medpace in Zurich, Switzerland. Dr. Sauniere brings a wealth of European scientific and regulatory expertise to Medpace enabling the building of strong multinational teams conducting trials with hands-on...
Medpace, Inc. Adds Medical Director, Dr. Fred Sauniere, MD, PhD, Strengthening Regulatory Expertise and Clinical Development Capabilities in Europe.
- 2009-03-10
CINCINNATI, OH, Mar 10, 2009 Marketwire via COMTEX -- Medpace today announced the addition of Dr. Fred Sauniere, MD, PhD as a Medical Director to be located at Medpace in Zurich, Switzerland. Dr. Sauniere brings a wealth of European scientific and regulatory expertise to ...
Medpace, Inc. Celebrates the First Year Success at the Medpace Clinical Pharmacology Unit (MCPU)
- 2009-01-28
Medpace celebrated an important milestone in its continuing growth and success as a full-service global clinical development organization -- the one-year anniversary of the Medpace Clinical Pharmacology Unit MCPU located in Cincinnati, OH. Within the first year of operation, the Medpace CPU has attracted top level scientific projects including...
Medpace Adds Executive Medical Director, Dr. Thomas G. Todaro, MD, JD, FACC, FCLM, Strengthening Therapeutic Expertise in Cardiology
- 2009-01-07
Medpace, Inc. today announced the addition of Dr. Thomas G. Todaro, MD, JD, FACC, FCLM as an Executive Medical Director, continuing their strategy of building onto a strong existing therapeutic team of scientists. Dr. Todaro joins a group considered industry leaders in development of pharmaceuticals...
Medpace Strengthens Clinical Development Services With Medpace Bioanalytical Laboratories
- 2008-12-16
Medpace, Inc., a leading full-service global clinical research organization, today announced the opening of the new Medpace Bioanalytical Laboratories, strengthening its suite of clinical development services for Pharmaceutical and Biotechnology companies. The new Laboratory complements services provided by other Medpace research facilities, such as Medpace Clinical...
Medpace Adds Medical Director, Dr. Bernard E. Ilson, MD, FACP Building Their Clinical Expertise in Nephrology and Clinical Pharmacology
- 2008-12-11
Medpace, Inc. today announced the addition of Dr. Bernard E. Ilson MD, FACP, as Medical Director building on their therapeutic focus in nephrology and broadening strength in clinical pharmacology . Dr. Ilson has over 21 years of experience in clinical drug development with GlaxoSmithKline Pharamceuticals...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| August Troendle | President and CEO of Medpace |
| Jonathan Isaacsohn | Vice President, Medical and Regulatory Affairs |
| Susan Burwig | Vice President, Clinical Operations |
| Weimin Gai | Vice President, Data Management and Biostatistics |
| Alexander Gissler | Managing Director, Medpace Germany Gmbh. |
| David G Orloff | Medical Director |
| Michael Fowler | Director, Medpace Laboratories |
| Yun Le | Director, Information Technology |
| Organization | Position | Status |
|---|---|---|
| Medpace, Inc. | President and CEO of Medpace | Current |
| Organization | Position | Status |
|---|---|---|
| Medpace, Inc. | Vice President, Medical and Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Medpace, Inc. | Vice President, Clinical Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Medpace, Inc. | Vice President, Data Management and Biostatistics | Current |
| Organization | Position | Status |
|---|---|---|
| Medpace, Inc. | Managing Director, Medpace Germany Gmbh. | Current |
| Organization | Position | Status |
|---|---|---|
| Medpace, Inc. | Medical Director | Current |
| Intekrin Therapeutics, Inc. | Board of Directors | Current |
| Harvard College | Former | |
| New York University School of Medicine | Former |
| Organization | Position | Status |
|---|---|---|
| Medpace, Inc. | Director, Medpace Laboratories | Current |
| Organization | Position | Status |
|---|---|---|
| Medpace, Inc. | Director, Information Technology | Current |
Industry Transcripts by Seeking Alpha
-
Fifth Street Finance Corp. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Dec 10, 2009about FSC
-
SAIC, Inc. F3Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about SAI
-
Casella Waste Systems Inc. F2Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 03, 2009about CWST
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES
IndustryTop Rated
Presented by American Express